Heterocycles as potassium channel modulators
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
15.11.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, seizure, retinal degeneration, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety, neuronal degeneration and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions. |
---|---|
AbstractList | Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, seizure, retinal degeneration, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety, neuronal degeneration and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions. |
Author | WOLF-GOUVEIA LILLI ANN ATKINSON ROBERT N CHRISTOS THOMAS EUGENE BAROLLI MARIA GRACIELA AMATO GEORGE S SUTO MARK J |
Author_xml | – fullname: CHRISTOS THOMAS EUGENE – fullname: AMATO GEORGE S – fullname: SUTO MARK J – fullname: WOLF-GOUVEIA LILLI ANN – fullname: ATKINSON ROBERT N – fullname: BAROLLI MARIA GRACIELA |
BookMark | eNrjYmDJy89L5WTQ8UgtSS3KT65MzkktVkgsVijIL0ksLs4szVVIzkjMy0vNUcjNTynNSSzJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWBqYWRuYmTkbGRCgBAHHuK-0 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Forestry Agriculture |
ExternalDocumentID | US8058274B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US8058274B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:59:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US8058274B23 |
Notes | Application Number: US20080193639 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111115&DB=EPODOC&CC=US&NR=8058274B2 |
ParticipantIDs | epo_espacenet_US8058274B2 |
PublicationCentury | 2000 |
PublicationDate | 20111115 |
PublicationDateYYYYMMDD | 2011-11-15 |
PublicationDate_xml | – month: 11 year: 2011 text: 20111115 day: 15 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | WOLF-GOUVEIA LILLI ANN ATKINSON ROBERT N CHRISTOS THOMAS EUGENE BAROLLI MARIA GRACIELA ICAGEN, INC AMATO GEORGE S SUTO MARK J |
RelatedCompanies_xml | – name: AMATO GEORGE S – name: ATKINSON ROBERT N – name: ICAGEN, INC – name: CHRISTOS THOMAS EUGENE – name: SUTO MARK J – name: BAROLLI MARIA GRACIELA – name: WOLF-GOUVEIA LILLI ANN |
Score | 2.830955 |
Snippet | Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES CHEMISTRY FISHING FORESTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING |
Title | Heterocycles as potassium channel modulators |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111115&DB=EPODOC&locale=&CC=US&NR=8058274B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKV6etCrOG32QPll0W68PReyNIrgNt8rextKkUnBtWTvEf-9JaKcvGvIQEghJyHfOycm5ANzaNGX6gFBV6w-W_IFiqxbKDWqi0cTQGMFLIqJ9jowo1p7n-rwDWesLI-KEforgiIioBPFeC3pd_iixfGFbWd2TDLuKx3Dm-Apt1X1YdMV3nWAy9see4nlOPFVGr471oFv4AHORWu-gFG1yMARvLndKKX9zlPAIdic4WV4fQ4flEhw-va-bKBhMgn2vTcMmwR5Pntk0X5qPcGw2mKxO4C7iFi1F8sXt2-RlJZdFjRJxtlnJ3Ks3Zx_yqqA8S1exrk5BDoOZF6m4nsV274t4ul358Ay6eZGzc5CJyYZJ30oNkxjIgTnoEmoRrsWxU5T5e9D7c5qLf8Yu4UDoTHnVr6BbrzfsGpluTW7EcX0DBWqGOg |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haERPihrwcwezk4sC29gOi3Eby1QYRMBwI3TrzBJZFzZi_O99bQZ60aaHpk2atunvvdfX9wFwY0Yx1dokUtRWe8EfKKZioNyghGoU6ioleElEtM9A96fq80ybVSDZ-MKIOKGfIjgiIipEvBeCXmc_SixX2FbmdyTBLvbgTSxXjjbqPiya7NpWbzR0h47sONZ0LAevlnGvGfgAs5Fa76CE3eVg6L3Z3Ckl-81RvEPYHeFkaXEEFZrW4eDxfVVGwaB1qDmbNGx12OPJM8vmoPwIx2aJyfwYbn1u0cLCL27fJi1yKWMFSsTJeilxr96UfkhLFvEsXWyVn4Dk9SaOr-B65tu9z6fj7co7p1BNWUobIJEu7YQtI9a7REcOzEEXRgbhWhwzRpm_Cc0_pzn7Z-waav5k0J_3n4KXc9gX-lNetQuoFqs1vUQGXJArcXTffOGJLQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Heterocycles+as+potassium+channel+modulators&rft.inventor=CHRISTOS+THOMAS+EUGENE&rft.inventor=AMATO+GEORGE+S&rft.inventor=SUTO+MARK+J&rft.inventor=WOLF-GOUVEIA+LILLI+ANN&rft.inventor=ATKINSON+ROBERT+N&rft.inventor=BAROLLI+MARIA+GRACIELA&rft.date=2011-11-15&rft.externalDBID=B2&rft.externalDocID=US8058274B2 |